Health
Australian firm says its nasal spray reduced coronavirus growth in animal study – The Tribune
Ena Respiratory ready to test INNA-051 in human trials in less than four months
Sydney, September 28
Australian biotech company Ena Respiratory said on Monday that a nasal spray it is developing to improve the human immune system to fight common cold and flu significantly reduced the growth of the coronavirus in a recent study on animals.
A study on ferrets showed the product dubbed INNA-051, which could be used complementary to vaccines, lowered the levels of the virus that causes COVID-19 by up to 96%, the company said.
The study was led by British government agency Pu…
-
Business16 hours agoCould a small investor today match the historic returns of Warren Buffett?
-
Business8 hours agoWhat’s Macquarie’s price target on Mineral Resources shares?
-
Noosa News22 hours agoHomicide investigation, Torquay – Sunshine Coast
-
General15 hours agoPope Leo condemns wealthy living in a bubble of luxury